Stage IIIB Breast Cancer AJCC v7 Recruiting Phase 2 Trials for Capecitabine (DB01101)

IndicationStatusPhase
DBCOND0092287 (Stage IIIB Breast Cancer AJCC v7)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03872388Atorvastatin in Treating Patients With Stages IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving Neoadjuvant ChemotherapyTreatment